Citylabs Customer YourGene Health to Develop Covid-19 Tests

“We are pleased to be able to utilise our high quality manufacturing skills to support Novacyt in the production of a key diagnostic test for COVID-19”.

Lyn Rees, CEO of Yourgene

Yourgene, a leading international molecular diagnostics group, announces the signing of an agreement for contract manufacturing services with Novacyt S.A., an international specialist in clinical diagnostics, to support the production of COVID-19 diagnostic tests developed by Primerdesign, Novacyt’s molecular diagnostics division.

Yourgene will make use of its state-of-the-art manufacturing facility at Citylabs in Manchester to work alongside Novacyt to ramp-up production of their COVID-19 test. The first batches are expected to be shipped from the Citylabs site over the next few weeks.
In addition to supporting manufacturing efforts, the Company is also in the process of expanding its laboratory capabilities to support the NHS in COVID-19 laboratory service testing. This is developing quickly, and the Company will update the market as and when these capabilities are in place and set to be utilised.

Lyn Rees, CEO of Yourgene, commented: “This manufacturing agreement illustrates that we have an incredibly skilled workforce and flexible manufacturing capabilities to support diagnostic test developers at critical times”.

Expanding into another diagnostic test aligns with Yourgene’s strategy to expand the Company’s product portfolio and bring new products to market.